Alzheimer’s Drug & Dermatitis JAK inhibitor Among New EU Filings

AstraZeneca’s New Lupus Treatment Is Also Under Review

 
• By Neena Brizmohun
  
Alzheimers_677117191_Atthapon-Raksthaput_1200.jpg
The EU marketing application for aducanumab is under review for Alzheimer's disease • Source: Shutterstock

More from Europe

More from Geography